Literature DB >> 15366372

Wa5 is a novel ENU-induced antimorphic allele of the epidermal growth factor receptor.

Daekee Lee1, Sally H Cross, Karen E Strunk, Joanne E Morgan, Candice L Bailey, Ian J Jackson, David W Threadgill.   

Abstract

Mice heterozygous for the N-ethyl-N-nitrosourea-induced Waved-5 (Wa5) mutation, isolated in a screen for dominant, visible mutations, exhibit a wavy coat similar to mice homozygous for the recessive Tgfa wa1 or Egfr wa2 alleles. In this study, we show that Wa5 is a new allele of Egfr (Egfr Wa5) containing a missense mutation within the coding region for the highly conserved DFG motif of the tyrosine kinase domain. In vivo analysis of placental development, modification of Apc Min tumorigenesis, and levels of EGF-dependent EGFR phosphorylation demonstrates that Egfr Wa5 functions as an antimorphic allele, recapitulating many abnormalities associated with reduced EGFR activity. Furthermore, Egfr wa5 enhances Egfr Wa2 compound or Tgfa tm1Dcl double mutants exposing additional EGFR-dependent phenotypes. In vitro characterization shows that the antimorphic property of Egfr Wa5 is caused by a kinase-dead receptor acting as a dominant negative.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15366372     DOI: 10.1007/s00335-004-2384-2

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  53 in total

1.  Novel ENU-induced eye mutations in the mouse: models for human eye disease.

Authors:  Caroline Thaung; Katrine West; Brian J Clark; Lisa McKie; Joanne E Morgan; Karen Arnold; Patrick M Nolan; Jo Peters; A Jackie Hunter; Steve D M Brown; Ian J Jackson; Sally H Cross
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

2.  Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells.

Authors:  Y Chen; D Yee; K Dains; A Chatterjee; J Cavalcoli; E Schneider; J Om; R P Woychik; T Magnuson
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development.

Authors:  D Z Wang; V E Hammond; H E Abud; I Bertoncello; J W McAvoy; D D Bowtell
Journal:  Genes Dev       Date:  1997-02-01       Impact factor: 11.361

4.  Nucleotide-binding properties of kinase-deficient epidermal-growth-factor-receptor mutants.

Authors:  K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 5.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

6.  Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus.

Authors:  J H Hallsson; J Favor; C Hodgkinson; T Glaser; M L Lamoreux; R Magnúsdóttir; G J Gunnarsson; H O Sweet; N G Copeland; N A Jenkins; E Steingrímsson
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

7.  Mice harboring a defective epidermal growth factor receptor (waved-2) have an increased susceptibility to acute dextran sulfate-induced colitis.

Authors:  B Egger; M W Büchler; J Lakshmanan; P Moore; V E Eysselein
Journal:  Scand J Gastroenterol       Date:  2000-11       Impact factor: 2.423

8.  Mom1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice.

Authors:  K A Gould; W F Dietrich; N Borenstein; E S Lander; W F Dove
Journal:  Genetics       Date:  1996-12       Impact factor: 4.562

9.  Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice.

Authors:  P C Marker; K Seung; A E Bland; L B Russell; D M Kingsley
Journal:  Genetics       Date:  1997-02       Impact factor: 4.562

10.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype.

Authors:  D W Threadgill; A A Dlugosz; L A Hansen; T Tennenbaum; U Lichti; D Yee; C LaMantia; T Mourton; K Herrup; R C Harris
Journal:  Science       Date:  1995-07-14       Impact factor: 47.728

View more
  32 in total

1.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

2.  The critical role of the epidermal growth factor receptor in endochondral ossification.

Authors:  Xianrong Zhang; Valerie A Siclari; Shenghui Lan; Ji Zhu; Eiki Koyama; Holly L Dupuis; Motomi Enomoto-Iwamoto; Frank Beier; Ling Qin
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

3.  Placental and embryonic growth restriction in mice with reduced function epidermal growth factor receptor alleles.

Authors:  Jennifer Dackor; Kathleen M Caron; David W Threadgill
Journal:  Genetics       Date:  2009-06-29       Impact factor: 4.562

4.  TNF transactivation of EGFR stimulates cytoprotective COX-2 expression in gastrointestinal epithelial cells.

Authors:  Stuart S Hobbs; Jeremy A Goettel; Dongchun Liang; Fang Yan; Karen L Edelblum; Mark R Frey; Matthew T Mullane; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-05-12       Impact factor: 4.052

5.  In vivo evidence for epidermal growth factor receptor (EGFR)-mediated release of prolactin from the pituitary gland.

Authors:  Maik Dahlhoff; Andreas Blutke; Rüdiger Wanke; Eckhard Wolf; Marlon R Schneider
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

6.  Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; M Kay Washington; Yan Shi; LinShu Liu; Rupesh Chaturvedi; Richard M Peek; Keith T Wilson; D Brent Polk
Journal:  J Clin Invest       Date:  2011-05-23       Impact factor: 14.808

7.  Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways.

Authors:  Xianrong Zhang; Ji Zhu; Yumei Li; Tiao Lin; Valerie A Siclari; Abhishek Chandra; Elena M Candela; Eiki Koyama; Motomi Enomoto-Iwamoto; Ling Qin
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

8.  Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium.

Authors:  Daekee Lee; Ming Yu; Eunjung Lee; Hyunok Kim; Yanan Yang; Kyoungmi Kim; Christina Pannicia; Jonathan M Kurie; David W Threadgill
Journal:  J Clin Invest       Date:  2009-08-17       Impact factor: 14.808

9.  Induction of COX-2 expression by Helicobacter pylori is mediated by activation of epidermal growth factor receptor in gastric epithelial cells.

Authors:  Johanna C Sierra; Stuart Hobbs; Rupesh Chaturvedi; Fang Yan; Keith T Wilson; Richard M Peek; D Brent Polk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-05-16       Impact factor: 4.052

10.  Deficiency of TNFalpha converting enzyme (TACE/ADAM17) causes a lean, hypermetabolic phenotype in mice.

Authors:  Richard W Gelling; Wenbo Yan; Salwa Al-Noori; Aaron Pardini; Gregory J Morton; Kayoko Ogimoto; Michael W Schwartz; Peter J Dempsey
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.